4 results match your criteria: "Hackensack Palisades Medical Center[Affiliation]"
The Impact of Tumor Stage and Histopathology on Survival Outcomes in Esophageal Cancer Patients over the Past Decade.
Med Sci (Basel)
December 2024
Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA.
Background: Esophageal cancer (EC) is the sixth leading cause of cancer-related mortality worldwide, continuing to be a significant public health concern. The purpose of this study is to assess the impact of staging and histopathology of EC on associated mortality. The study also aims to further investigate clinical characteristics, prognostic factors, and survival outcomes in patients diagnosed with EC between 2010 and 2017.
View Article and Find Full Text PDFSurvival Outcomes of U.S. Patients with CMML: A Two-Decade Analysis from the SEER Database.
Med Sci (Basel)
October 2024
Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA.
Chronic Myelomonocytic Leukemia (CMML) is a rare and aggressive form of leukemia with characteristics of both myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDSs). This study aims to explore the clinical features, survival outcomes, and prognostic factors in CMML patients over the past 20 years using a large sample. The study data from 4124 patients diagnosed with CMML between 2000 and 2017 were sourced from the SEER database.
View Article and Find Full Text PDFTherapeutics involved in managing initial and recurrent infection: An updated literature review.
World J Gastrointest Pharmacol Ther
September 2024
Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, United States.
Article Synopsis
- The increasing incidence of Clostridioides difficile infection (CDI) is largely due to recurrent hospitalizations and the impact of antibiotics on the gut microbiome.
- Current treatment options are limited to three main antibiotics, but rising drug resistance and recurrent infections pose significant challenges, especially among vulnerable populations like the elderly and immunocompromised.
- New treatments, including monoclonal antibodies like bezlotoxumab and fecal microbiota transplants, are being researched to better manage and prevent CDI, alongside an overview of challenges faced in treating this infection.
Factors Affecting Survival Outcomes in Neuroendocrine Tumor of the Appendix over the Past Two Decades.
Diseases
May 2024
Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA.
Background: Appendiceal neuroendocrine tumors (NETs) rank as the third most frequent neoplasm affecting the appendix, originating from enterochromaffin cells. This study aims to evaluate the influence of various prognostic factors on the mortality rates of patients diagnosed with NETs of the appendix.
Methods: Conducted retrospectively, the study involved 3346 patients, utilizing data sourced from the Surveillance, Epidemiology, and End Results (SEER) database.